SCHEMBL1741017

SCHEMBL1741017

CC(C)Oc1ncc(Nc2ncc(C#N)c(N(C)C3CC(C)(C)NC(C)(C)C3)n2)cc1-c1nnnn1C

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 3/20 0.33
LRRK2 Q5S007 2/20 0.32
KCNH2 Q12809 2/20 0.32
CHEK1 O14757 2/20 0.31
S1PR1 P21453 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1741333 0.92 KCNH2 (0.32) MAP3K14LRRK2KCNH2S1PR1
SCHEMBL1740122 0.86 SYK (0.35) LRRK2KCNH2
SCHEMBL1740751 0.85 PRKCQ (0.37) MAP3K14LRRK2CHEK1
SCHEMBL1742251 0.79 PRKCQ (0.46) LRRK2CHEK1
SCHEMBL1739955 0.77 LRRK2 (0.38) MAP3K14LRRK2KCNH2CHEK1S1PR1
SCHEMBL1740853 0.77 PRKCQ (0.48) LRRK2
SCHEMBL1740730 0.76 LRRK2 (0.41) MAP3K14LRRK2KCNH2CHEK1S1PR1
SCHEMBL1742542 0.73 PRKCQ (0.35) MAP3K14LRRK2KCNH2
SCHEMBL1739732 0.71 PRKCQ (0.44) LRRK2CHEK1
SCHEMBL1740135 0.70 PRKCQ (0.43) LRRK2KCNH2CHEK1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2389373-A1 DERIVATIVES OF N2-(3-PYRIDIL OR PHENYL)-N4-(4-PIPERIDYL)-2,4-PYRIMIDINEDIAMINE USEFUL IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE OR PROLIFERATIVE DISEASES Rigel Pharmaceuticals, Inc. (US) 2011-11-30 EP disclosed
US-20110253835-A1 AIRCRAFT INTERIOR LAVATORY BE INTELLECTUAL PROPERTY, INC. (US) 2011-10-20 US disclosed
WO-2010090875-A1 DERIVATIVES OF N2-(3-PYRIDIL OR PHENYL)-N4-(4-PIPERIDYL)-2,4-PYRIMIDINEDIAMINE USEFUL IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE OR PROLIFERATIVE DISEASES RIGEL PHARMACEUTICALS, INC. (US) 2010-08-12 WO disclosed